Citations (143)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (16)
Jiahui Zhang, Jingyi Fan, Mariusz Skwarczynski, Rachel J Stephenson, Istvan Toth & Waleed M Hussein. (2022) Peptide-Based Nanovaccines in the Treatment of Cervical Cancer: A Review of Recent Advances. International Journal of Nanomedicine 17, pages 869-900.
Read now
Read now
Yina Cun, Chuanyin Li, Lei Shi, Ming Sun, Shuying Dai, Le Sun, Li Shi & Yufeng Yao. (2021) COVID-19 coronavirus vaccine T cell epitope prediction analysis based on distributions of HLA class I loci (HLA-A, -B, -C) across global populations. Human Vaccines & Immunotherapeutics 17:4, pages 1097-1108.
Read now
Read now
Firzan Nainu, Rufika Shari Abidin, Muh. Akbar Bahar, Andri Frediansyah, Talha Bin Emran, Ali A Rabaan, Kuldeep Dhama & Harapan Harapan. (2020) SARS-CoV-2 reinfection and implications for vaccine development. Human Vaccines & Immunotherapeutics 16:12, pages 3061-3073.
Read now
Read now
Sijin Li, Qishu Zhang, Hongmei Bai, Weiwei Huang, Congyan Shu, Chao Ye, Wenjia Sun & Yanbing Ma. (2019) Self-Assembled Nanofibers Elicit Potent HPV16 E7-Specific Cellular Immunity And Abolish Established TC-1 Graft Tumor. International Journal of Nanomedicine 14, pages 8209-8219.
Read now
Read now
Cristina Scavone, Cristina Di Mauro, Simona Brusco, Michele Bertini, Gabriella di Mauro, Concetta Rafaniello, Liberata Sportiello, Francesco Rossi & Annalisa Capuano. (2019) Surveillance of adverse events following immunization related to human papillomavirus vaccines: 12 years of vaccinovigilance in Southern Italy. Expert Opinion on Drug Safety 18:5, pages 427-433.
Read now
Read now
Xiaojie Chu, Yang Li, Weiwei Huang, Xuejun Feng, Pengyan Sun, Yufeng Yao, Xu Yang, Wenjia Sun, Hongmei Bai, Cunbao Liu & Yanbing Ma. (2018) Combined immunization against TGF-β1 enhances HPV16 E7-specific vaccine-elicited antitumour immunity in mice with grafted TC-1 tumours. Artificial Cells, Nanomedicine, and Biotechnology 46:sup2, pages 1199-1209.
Read now
Read now
Piyachat Roopngam, Kewei Liu, Lin Mei, Yi Zheng, Xianbing Zhu, Hsiang-I Tsai & Laiqiang Huang. (2016) Hepatitis C virus E2 protein encapsulation into poly d, l-lactic-co-glycolide microspheres could induce mice cytotoxic T-cell response. International Journal of Nanomedicine 11, pages 5361-5370.
Read now
Read now
Xiaojie Chu, Yang Li, Qiong Long, Ye Xia, Yufeng Yao, Wenjia Sun, Weiwei Huang, Xu Yang, Cunbao Liu & Yanbing Ma. (2016) Chimeric HBcAg virus-like particles presenting a HPV 16 E7 epitope significantly suppressed tumor progression through preventive or therapeutic immunization in a TC-1-grafted mouse model. International Journal of Nanomedicine 11, pages 2417-2429.
Read now
Read now
Andrew Yang, Jessica Jeang, Kevin Cheng, Ting Cheng, Benjamin Yang, T.-C. Wu & Chien-Fu Hung. (2016) Current state in the development of candidate therapeutic HPV vaccines. Expert Review of Vaccines 15:8, pages 989-1007.
Read now
Read now
Zhida Liu, Hang Zhou, Wenjun Wang, Yang-Xin Fu & Mingzhao Zhu. (2016) A novel dendritic cell targeting HPV16 E7 synthetic vaccine in combination with PD-L1 blockade elicits therapeutic antitumor immunity in mice. OncoImmunology 5:6.
Read now
Read now
Kuan-Yin Shen, Li-Sheng Chang, Chih-Hsiang Leng & Shih-Jen Liu. (2015) Self-adjuvanting lipoimmunogens for therapeutic HPV vaccine development: potential clinical impact. Expert Review of Vaccines 14:3, pages 383-394.
Read now
Read now
Kuan-Yin Shen, Ying-Chyi Song, I-Hua Chen, Pele Chong & Shih-Jen Liu. (2014) Depletion of tumor-associated macrophages enhances the anti-tumor immunity induced by a Toll-like receptor agonist-conjugated peptide. Human Vaccines & Immunotherapeutics 10:11, pages 3241-3250.
Read now
Read now
Joshua W Wang & Richard BS Roden. (2013) Virus-like particles for the prevention of human papillomavirus-associated malignancies. Expert Review of Vaccines 12:2, pages 129-141.
Read now
Read now
Ching-Liang Chu, Dz-Chi Chen & Chi-Chen Lin. (2011) A novel adjuvant Ling Zhi-8 for cancer DNA vaccines. Human Vaccines 7:11, pages 1161-1164.
Read now
Read now
Colomba Giorgi, Rosella Franconi & Edward P Rybicki. (2010) Human papillomavirus vaccines in plants. Expert Review of Vaccines 9:8, pages 913-924.
Read now
Read now
Archana Monie, Shaw-Wei D Tsen, Chien-Fu Hung & T-C Wu. (2009) Therapeutic HPV DNA vaccines. Expert Review of Vaccines 8:9, pages 1221-1235.
Read now
Read now
Articles from other publishers (127)
Meenu Jain, Dhananjay Yadav, Urmila Jarouliya, Vishal Chavda, Arun Kumar Yadav, Bipin Chaurasia & Minseok Song. (2023) Epidemiology, Molecular Pathogenesis, Immuno-Pathogenesis, Immune Escape Mechanisms and Vaccine Evaluation for HPV-Associated Carcinogenesis. Pathogens 12:12, pages 1380.
Crossref
Crossref
Kainat Ahmed & Sudhakar Jha. (2023) Oncoviruses: How do they hijack their host and current treatment regimes. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1878:5, pages 188960.
Crossref
Crossref
Alexandre Santos Matos, Maria da Conceição Viana Invenção, Ingrid Andrêssa de Moura, Antonio Carlos de Freitas & Marcus Vinicius de Aragão Batista. (2023) Immunoinformatics applications in the development of therapeutic vaccines against human papillomavirus‐related infections and cervical cancer. Reviews in Medical Virology 33:5.
Crossref
Crossref
Shreya Chakraborty, Kanagavalli Ramasubbu, Manosi Banerjee, Menaka Priya Balaji, Yamini Vinayagam & Devi Rajeswari V. (2023) A systematic review on the molecular and clinical association between Human Papillomavirus and Human Immunodeficiency Virus co‐infection in Head, Neck and Oral squamous cell carcinoma. Reviews in Medical Virology 33:5.
Crossref
Crossref
Kirti Pandey, Stacie S. Wang, Nicole A. Mifsud, Pouya Faridi, Alexander J. Davenport, Andrew I. Webb, Jarrod J. Sandow, Rochelle Ayala, Michelle Monje, Ryan S. Cross, Sri H. Ramarathinam, Misty R. Jenkins & Anthony W. Purcell. (2023) A combined immunopeptidomics, proteomics, and cell surface proteomics approach to identify immunotherapy targets for diffuse intrinsic pontine glioma. Frontiers in Oncology 13.
Crossref
Crossref
Mamoona Sarfaraz, Faiqa Anjum, Duaa Zahra, Ayesha Maqsood & Usman Ali Ashfaq. (2023) Recent Updates on Peptide Molecules in Drug and Vaccine Development. Current Pharmaceutical Design 29:20, pages 1564-1578.
Crossref
Crossref
Mehran Mahooti, Elahe Abdolalipour, Seyed Mohammad Miri & Amir Ghaemi. 2023. Probiotics in Anticancer Immunity. Probiotics in Anticancer Immunity
211
235
.
Avinash Khadela, Yesha Shah, Priya Mistry, Kunjan Bodiwala & Avinash CB. (2023) Immunomodulatory Therapy in Head and Neck Squamous Cell Carcinoma: Recent Advances and Clinical Prospects. Technology in Cancer Research & Treatment 22, pages 153303382211505.
Crossref
Crossref
Smita Kumari, Sudhanshu Sharma, Dia Advani, Akanksha Khosla, Pravir Kumar & Rashmi K. Ambasta. (2021) Unboxing the molecular modalities of mutagens in cancer. Environmental Science and Pollution Research 29:41, pages 62111-62159.
Crossref
Crossref
Trisha M. Wise-Draper, Houda Bahig, Marion Tonneau, Vidhya Karivedu & Barbara Burtness. (2022) Current Therapy for Metastatic Head and Neck Cancer: Evidence, Opportunities, and Challenges. American Society of Clinical Oncology Educational Book:42, pages 527-540.
Crossref
Crossref
Ayazhan Akhatova, Chee Kai Chan, Azliyati Azizan & Gulzhanat Aimagambetova. (2021) The Efficacy of Therapeutic DNA Vaccines Expressing the Human Papillomavirus E6 and E7 Oncoproteins for Treatment of Cervical Cancer: Systematic Review. Vaccines 10:1, pages 53.
Crossref
Crossref
Jade Z. Zhou, Jessica Jou & Ezra Cohen. (2021) Vaccine Strategies for Human Papillomavirus-Associated Head and Neck Cancers. Cancers 14:1, pages 33.
Crossref
Crossref
Fariba Dorostkar, Arash Arashkia, Farzin Roohvand, Zabihollah Shoja, Mohsen Navari, Maryam Mashhadi Abolghasem Shirazi, Zahra Shahosseini, Mohammad Farahmand, Mohammad Sadegh Shams nosrati & Somayeh Jalilvand. (2021) Co‐administration of 2’3’-cGAMP STING activator and CpG-C adjuvants with a mutated form of HPV 16 E7 protein leads to tumor growth inhibition in the mouse model. Infectious Agents and Cancer 16:1.
Crossref
Crossref
Zhuoli Yang, Hua Liu, Ran Song, Wenxiu Lu, Haibo Wang, Siyu Gu, Xuedi Cao, Yibin Chen, Jihuan Liang, Qiong Qin, Xiaomei Yang, Duiping Feng & Junqi He. (2021) Reduced MAGI3 level by HPV18E6 contributes to Wnt/β‐catenin signaling activation and cervical cancer progression. FEBS Open Bio 11:11, pages 3051-3062.
Crossref
Crossref
Farzaneh Kordbacheh & Camile S. Farah. (2021) Current and Emerging Molecular Therapies for Head and Neck Squamous Cell Carcinoma. Cancers 13:21, pages 5471.
Crossref
Crossref
Patrick Neckermann, Ditte Rahbaek Boilesen, Torsten Willert, Cordula Pertl, Silke Schrödel, Christian Thirion, Benedikt Asbach, Peter Johannes Holst & Ralf Wagner. (2021) Design and Immunological Validation of Macaca fascicularis Papillomavirus Type 3 Based Vaccine Candidates in Outbred Mice: Basis for Future Testing of a Therapeutic Papillomavirus Vaccine in NHPs. Frontiers in Immunology 12.
Crossref
Crossref
Maria Lobato Gómez, Xin Huang, Derry Alvarez, Wenshu He, Can Baysal, Changfu Zhu, Victoria Armario‐Najera, Amaya Blanco Perera, Pedro Cerda Bennasser, Andera Saba‐Mayoral, Guillermo Sobrino‐Mengual, Ashwin Vargheese, Rita Abranches, Isabel Alexandra Abreu, Shanmugaraj Balamurugan, Ralph Bock, Johannes.F. Buyel, Nicolau B. da Cunha, Henry Daniell, Roland Faller, André Folgado, Iyappan Gowtham, Suvi T. Häkkinen, Shashi Kumar, Sathish Kumar Ramalingam, Cristiano Lacorte, George P. Lomonossoff, Ines M. Luís, Julian K.‐C. Ma, Karen. A. McDonald, Andre Murad, Somen Nandi, Barry O’Keefe, Kirsi‐Marja Oksman‐Caldentey, Subramanian Parthiban, Mathew J. Paul, Daniel Ponndorf, Elibio Rech, Julio C. M. Rodrigues, Stephanie Ruf, Stefan Schillberg, Jennifer Schwestka, Priya S. Shah, Rahul Singh, Eva Stoger, Richard M. Twyman, Inchakalody P. Varghese, Giovanni R. Vianna, Gina Webster, Ruud H. P. Wilbers, Teresa Capell & Paul Christou. (2021) Contributions of the international plant science community to the fight against human infectious diseases – part 1: epidemic and pandemic diseases. Plant Biotechnology Journal 19:10, pages 1901-1920.
Crossref
Crossref
Maxwell Y. Lee & Clint T. Allen. (2021) Immunotherapy for HPV Malignancies. Seminars in Radiation Oncology 31:4, pages 361-370.
Crossref
Crossref
Louise Ferrall, Ken Y. Lin, Richard B.S. Roden, Chien-Fu Hung & T.-C. Wu. (2021) Cervical Cancer Immunotherapy: Facts and Hopes. Clinical Cancer Research 27:18, pages 4953-4973.
Crossref
Crossref
Hanul Choi, Jungmin Chun, Mina Park, Suyeon Kim, Nahyun Kim, Hee-Jung Lee, Minjee Kim, Ha Youn Shin, Yu-Kyoung Oh & Young Bong Kim. (2021) The Safe Baculovirus-Based PrM/E DNA Vaccine Protected Fetuses against Zika Virus in A129 Mice. Vaccines 9:5, pages 438.
Crossref
Crossref
Emily Farmer, Max A. Cheng, Chien-Fu Hung & T.-C. Wu. 2021. Viruses and Human Cancer. Viruses and Human Cancer
157
195
.
Ali Akbari & Jafar Rezaie. (2020) Potential therapeutic application of mesenchymal stem cell-derived exosomes in SARS-CoV-2 pneumonia. Stem Cell Research & Therapy 11:1.
Crossref
Crossref
Amit Kumar Gupta & Manoj Kumar. (2020) HPVomics: An integrated resource for the human papillomavirus epitome and therapeutics. Genomics 112:6, pages 4853-4862.
Crossref
Crossref
Mehdi Hassanpour, Jafar Rezaie, Mohammad Nouri & Yunes Panahi. (2020) The role of extracellular vesicles in COVID-19 virus infection. Infection, Genetics and Evolution 85, pages 104422.
Crossref
Crossref
Ahmet Murat Aydin, Jad Chahoud, Jacob J. Adashek, Mounsif Azizi, Anthony Magliocco, Jeffrey S. Ross, Andrea Necchi & Philippe E. Spiess. (2020) Understanding genomics and the immune environment of penile cancer to improve therapy. Nature Reviews Urology 17:10, pages 555-570.
Crossref
Crossref
Liqin Cheng, Yan Wang & Juan Du. (2020) Human Papillomavirus Vaccines: An Updated Review. Vaccines 8:3, pages 391.
Crossref
Crossref
Andrew T. Day, Carole Fakhry, Jasmin A. Tiro, Kristina R. Dahlstrom & Erich M. Sturgis. (2020) Considerations in Human Papillomavirus–Associated Oropharyngeal Cancer Screening. JAMA Otolaryngology–Head & Neck Surgery 146:7, pages 656.
Crossref
Crossref
Mohd. Saeed, Syed Mohd Faisal, Firoz Akhtar, Saheem Ahmad, Mousa M. Alreshidi, Mohd. Adnan Kausar, Shadab Kazmi, Amir Saeed, Mohd. Adnan & Ghulam Md Ashraf. (2020) Human Papillomavirus Induced Cervical and Oropharyngeal Cancers: From Mechanisms to Potential Immuno-therapeutic Strategies. Current Drug Metabolism 21:3, pages 167-177.
Crossref
Crossref
Husein Husein-ElAhmed. (2020) Could the human papillomavirus vaccine prevent recurrence of ano-genital warts?: a systematic review and meta-analysis. International Journal of STD & AIDS 31:7, pages 606-612.
Crossref
Crossref
Gloria Sierra, Stephanie Dorta-Estremera, Venkatesh L. Hegde, Sita M. K. Nookala, Ananta V. Yanamandra & K. Jagannadha Sastry. (2020) Intranasal Therapeutic Peptide Vaccine Promotes Efficient Induction and Trafficking of Cytotoxic T Cell Response for the Clearance of HPV Vaginal Tumors. Vaccines 8:2, pages 259.
Crossref
Crossref
Heidar Ali Panahi, Azam Bolhassani, Gholamreza Javadi, Zahra Noormohammadi & Elnaz Agi. (2020) Development of multiepitope therapeutic vaccines against the most prevalent high-risk human papillomaviruses. Immunotherapy 12:7, pages 459-479.
Crossref
Crossref
Alexander C. Cohen, Brandon M. Roane & Charles A. LeathIIIIII. (2020) Novel Therapeutics for Recurrent Cervical Cancer: Moving Towards Personalized Therapy. Drugs 80:3, pages 217-227.
Crossref
Crossref
Masumeh Haj Hodaei, Rudabeh Behzadi Anduhjerdi, Jalil Fallah Mehrabadi & Davoud Esmaeili. (2019) Cloning and expression of the L1 immunogenic protein of human papillomavirus genotype 16 by using Lactobacillus expression system. Gene Reports 17, pages 100521.
Crossref
Crossref
Ali Namvar, Azam Bolhassani, Gholamreza Javadi & Zahra Noormohammadi. (2019) In silico/In vivo analysis of high-risk papillomavirus L1 and L2 conserved sequences for development of cross-subtype prophylactic vaccine. Scientific Reports 9:1.
Crossref
Crossref
Ziyun Zhou, Hongying Yang, Lijuan Yang, Yueting Yao, Shuying Dai, Li Shi, Chuanyin Li, Longyu Yang, Zhiling Yan & Yufeng Yao. (2019) Human papillomavirus type 16 E6 and E7 gene variations associated with cervical cancer in a Han Chinese population. Infection, Genetics and Evolution 73, pages 13-20.
Crossref
Crossref
M. S. Vonsky, A. L. Runov, I. V. Gordeychuk & M. G. Isaguliants. (2019) Therapeutic Vaccines Against Human Papilloma Viruses: Achievements and Prospects. Biochemistry (Moscow) 84:7, pages 800-816.
Crossref
Crossref
Laura Martin-Gomez, Anna R. Giuliano, William J. Fulp, Jimmy Caudell, Michelle Echevarria, Bradley Sirak, Martha Abrahamsen, Kimberly A. Isaacs-Soriano, Juan C. Hernandez-Prera, Bruce M. Wenig, Kathryn Vorwald, Caitlin P. McMullen, J. Trad Wadsworth, Robbert J. Slebos & Christine H. Chung. (2019) Human Papillomavirus Genotype Detection in Oral Gargle Samples Among Men With Newly Diagnosed Oropharyngeal Squamous Cell Carcinoma. JAMA Otolaryngology–Head & Neck Surgery 145:5, pages 460.
Crossref
Crossref
N. Dumpa, K. Goel, Yuhan Guo, H. McFall, Amit Raviraj Pillai, Ashay Shukla, M. A. Repka & S. Narasimha Murthy. (2019) Stability of Vaccines. AAPS PharmSciTech 20:2.
Crossref
Crossref
Katrine Schneider, Christian Grønhøj, Christoffer Holst Hahn & Christian von Buchwald. (2018) Therapeutic human papillomavirus vaccines in head and neck cancer: A systematic review of current clinical trials. Vaccine 36:45, pages 6594-6605.
Crossref
Crossref
Shuying Dai, Yueting Yao, Zhiling Yan, Ziyun Zhou, Li Shi, Xiaona Wang, Le Sun, Rongping Zhang & Yufeng Yao. (2018) The association of human papillomavirus type 16 E2 variations with cervical cancer in a Han Chinese population. Infection, Genetics and Evolution 64, pages 241-248.
Crossref
Crossref
O. S. Alyautdina & M. A. Darmostukova. (2018) MODERN ASPECTS OF HUMAN PAPILLOMAVIRUS VACCINATION. Safety and Risk of Pharmacotherapy 6:3, pages 111-117.
Crossref
Crossref
Diogo Estêvão, Natália Rios Costa, Rui Gil da Costa & Rui Medeiros. (2018) CRISPR-Cas9 therapies in experimental mouse models of cancer. Future Oncology 14:20, pages 2083-2095.
Crossref
Crossref
Aleyo Chabeda, Romana J.R. Yanez, Renate Lamprecht, Ann E. Meyers, Edward P. Rybicki & Inga I. Hitzeroth. (2018) Therapeutic vaccines for high-risk HPV-associated diseases. Papillomavirus Research 5, pages 46-58.
Crossref
Crossref
Sabrina Nusrat Sabah, Md Amran Gazi, Rahvia Alam Sthity, Amena Binte Husain, Salwa Abdul Quyyum, Mustafizur Rahman & Md Rezaul Islam. (2016) Designing of Epitope-Focused Vaccine by Targeting E6 and E7 Conserved Protein Sequences: An Immuno-Informatics Approach in Human Papillomavirus 58 Isolates. Interdisciplinary Sciences: Computational Life Sciences 10:2, pages 251-260.
Crossref
Crossref
Abbas Khan, Muhammad Junaid, Aman Chandra Kaushik, Arif Ali, Syed Shujait Ali, Aamir Mehmood & Dong-Qing Wei. (2018) Computational identification, characterization and validation of potential antigenic peptide vaccines from hrHPVs E6 proteins using immunoinformatics and computational systems biology approaches. PLOS ONE 13:5, pages e0196484.
Crossref
Crossref
Romana J. R. Yanez, Renate Lamprecht, Milaid Granadillo, Isis Torrens, Elsa Arcalís, Eva Stöger, Edward P. Rybicki & Inga I. Hitzeroth. (2018)
LALF
32-51
-E7, a HPV-16 therapeutic vaccine candidate, forms protein body-like structures when expressed in
Nicotiana benthamiana
leaves
. Plant Biotechnology Journal 16:2, pages 628-637.
Crossref
Crossref
Edith Hanna, Mohammed Dany, Ossama Abbas, Firas Kreidieh & Mazen Kurban. (2018) Updates on the use of vaccines in dermatological conditions. Indian Journal of Dermatology, Venereology and Leprology 84:4, pages 388.
Crossref
Crossref
Jean‑Luc Brun, Jos� Rajaonarison, Nicolas Nocart, Laura Hoarau, St�phanie Brun & Isabelle Garrigue. (2017) Targeted immunotherapy of high‑grade cervical intra‑epithelial neoplasia: Expectations from clinical trials (Review). Molecular and Clinical Oncology.
Crossref
Crossref
Jianqiang Li, Si Chen, Jun Ge, Feng Lu, Sulin Ren, Zhiqiang Zhao, Xiuying Pu, Xiaoxiao Chen, Jiaojiao Sun & Yueqing Gu. (2017) A novel therapeutic vaccine composed of a rearranged human papillomavirus type 16 E6/E7 fusion protein and Fms-like tyrosine kinase-3 ligand induces CD8+ T cell responses and antitumor effect. Vaccine 35:47, pages 6459-6467.
Crossref
Crossref
Hyoung Jin Kim & Hong-Jin Kim. (2017) Current status and future prospects for human papillomavirus vaccines. Archives of Pharmacal Research 40:9, pages 1050-1063.
Crossref
Crossref
Romana J. R. Yanez, Renate Lamprecht, Milaid Granadillo, Brandon Weber, Isis Torrens, Edward P. Rybicki & Inga I. Hitzeroth. (2017) Expression optimization of a cell membrane-penetrating human papillomavirus type 16 therapeutic vaccine candidate in Nicotiana benthamiana. PLOS ONE 12:8, pages e0183177.
Crossref
Crossref
E. Ragonnaud, A. G. Pedersen & P. J. Holst. (2017) Breadth of T Cell Responses After Immunization with Adenovirus Vectors Encoding Ancestral Antigens or Polyvalent Papillomavirus Antigens. Scandinavian Journal of Immunology 85:3, pages 182-190.
Crossref
Crossref
Andrew Yang, Emily Farmer, John Lin, T.-C. Wu & Chien-Fu Hung. (2017) The current state of therapeutic and T cell-based vaccines against human papillomaviruses. Virus Research 231, pages 148-165.
Crossref
Crossref
Emeline Ragonnaud, Anne-Marie C. Andersson, Silmi Mariya, Anders G. Pedersen, Robert D. Burk, Antonella Folgori, Stefano Colloca, Riccardo Cortese, Alfredo Nicosia, Joko Pamungkas, Diah Iskandriati & Peter J. Holst. (2017) Therapeutic Vaccine Against Primate Papillomavirus Infections of the Cervix. Journal of Immunotherapy 40:2, pages 51-61.
Crossref
Crossref
Yuwei Chenzhang, Qiang Wen, Xianping Ding, Man Cao, Zuyi Chen, Xuemei Mu & Tao Wang. (2017) Identification of the impact on T- and B- cell epitopes of human papillomavirus type-16 E6 and E7 variant in Southwest China. Immunology Letters 181, pages 26-30.
Crossref
Crossref
Braira Wahid, Amjad Ali, Muhammad Idrees & Shazia Rafique. (2016) Immunotherapeutic strategies for sexually transmitted viral infections: HIV, HSV and HPV. Cellular Immunology 310, pages 1-13.
Crossref
Crossref
Simonetta Ausoni, Paolo Boscolo-Rizzo, Bhuvanesh Singh, Maria Cristina Da Mosto, Giacomo Spinato, Giancarlo Tirelli, Roberto Spinato & Giuseppe Azzarello. (2016) Targeting cellular and molecular drivers of head and neck squamous cell carcinoma: current options and emerging perspectives. Cancer and Metastasis Reviews 35:3, pages 413-426.
Crossref
Crossref
Julie Ahn & Simon R. A. Best. (2016) Adjuvant and Novel Treatment of Recurrent Respiratory Papillomatosis. Current Otorhinolaryngology Reports 4:2, pages 67-75.
Crossref
Crossref
Danielly S. Campos-Ferreira, Elaine V.M. Souza, Gustavo A. Nascimento, Deborah M.L. Zanforlin, Mariana S. Arruda, Monique F.S. Beltr?o, Aila L. Melo, Danyelly Bruneska & Jos? L. Lima-Filho. (2016) Electrochemical DNA biosensor for the detection of human papillomavirus E6 gene inserted in recombinant plasmid. Arabian Journal of Chemistry 9:3, pages 443-450.
Crossref
Crossref
Sarah M. Crafton & Ritu Salani. (2016) Beyond Chemotherapy: An Overview and Review of Targeted Therapy in Cervical Cancer. Clinical Therapeutics 38:3, pages 449-458.
Crossref
Crossref
Saeideh Milani, Mojgan Bandehpour, Zohreh Sharifi & Bahram Kazemi. (2016) The Role of Apollon Gene Silencing on Viablity and Radiosensitivity of Cervical Cancer Hela Cells. Brazilian Archives of Biology and Technology 59:0.
Crossref
Crossref
Massimiliano Bissa, Elena Illiano, Sole Pacchioni, Francesca Paolini, Carlo Zanotto, Carlo De Giuli Morghen, Silvia Massa, Rosella Franconi, Antonia Radaelli & Aldo Venuti. (2015) A prime/boost strategy using DNA/fowlpox recombinants expressing the genetically attenuated E6 protein as a putative vaccine against HPV-16-associated cancers. Journal of Translational Medicine 13:1.
Crossref
Crossref
Christoph Jindra, Bettina Huber, Saeed Shafti-Keramat, Markus Wolschek, Boris Ferko, Thomas Muster, Sabine Brandt & Reinhard Kirnbauer. (2015) Attenuated Recombinant Influenza A Virus Expressing HPV16 E6 and E7 as a Novel Therapeutic Vaccine Approach. PLOS ONE 10:9, pages e0138722.
Crossref
Crossref
Tetje C van der Sluis, Sjoerd H van der Burg, Ramon Arens & Cornelis JM Melief. (2015) New approaches in vaccine-based immunotherapy for human papillomavirus-induced cancer. Current Opinion in Immunology 35, pages 9-14.
Crossref
Crossref
Anoop Kumar, Showket Hussain, Inderjit Singh Yadav, Lutz Gissmann, K. Natarajan, Bhudev C. Das & Mausumi Bharadwaj. (2015) Identification of human papillomavirus-16 E6 variation in cervical cancer and their impact on T and B cell epitopes. Journal of Virological Methods 218, pages 51-58.
Crossref
Crossref
Mohammed Wahiduzzaman, Chandresh Sharma, Bindu Dey, Neerja Bhatla & Neeta Singh. (2015) Development of chimeric candidate vaccine against HPV18: a proof of concept. Immunologic Research 62:2, pages 189-197.
Crossref
Crossref
Frank R. Jones, Elizabeth S. Gabitzsch & Joseph P. Balint. The Ad5 [E1-, E2b-]-based vector: a new and versatile gene delivery platform. The Ad5 [E1-, E2b-]-based vector: a new and versatile gene delivery platform.
Sushil Kumar, Manash Biswas & Tony Jose. (2015) HPV vaccine: Current status and future directions. Medical Journal Armed Forces India 71:2, pages 171-177.
Crossref
Crossref
Massimiliano Bissa, Carlo Zanotto, Sole Pacchioni, Luca Volonté, Aldo Venuti, David Lembo, Carlo De Giuli Morghen & Antonia Radaelli. (2015) The L1 protein of human papilloma virus 16 expressed by a fowlpox virus recombinant can assemble into virus-like particles in mammalian cell lines but elicits a non-neutralising humoral response. Antiviral Research 116, pages 67-75.
Crossref
Crossref
Sara J. McKee, Anne-Sophie Bergot & Graham R. Leggatt. (2015) Recent progress in vaccination against human papillomavirus-mediated cervical cancer. Reviews in Medical Virology 25, pages 54-71.
Crossref
Crossref
Rodrigo Pinheiro Araldi, Jacqueline Mazzuchelli-de-Souza, Diego Grando Modolo, Edislane Barreiros de Souza, Thatiana Corrêa de Melo, Diva Denelle Spadacci-Morena, Roberta Fiusa Magnelli, Márcio Augusto Caldas Rocha de Carvalho, Paulo Luis de Sá Júnior, Rodrigo Franco de Carvalho, Willy Beçak & Rita de Cassia Stocco. (2015)
Mutagenic Potential of
Bos taurus
Papillomavirus Type 1 E6 Recombinant Protein: First Description
. BioMed Research International 2015, pages 1-15.
Crossref
Crossref
Mark Whitehead, Peter Öhlschläger, Fahad N Almajhdi, Leonor Alloza, Pablo Marzábal, Ann E Meyers, Inga I Hitzeroth & Edward P Rybicki. (2014) Human papillomavirus (HPV) type 16 E7 protein bodies cause tumour regression in mice. BMC Cancer 14:1.
Crossref
Crossref
Ângela Sousa, Patrícia Pereira, Fani Sousa & João A. Queiroz. (2014) Binding mechanisms for histamine and agmatine ligands in plasmid deoxyribonucleic acid purifications. Journal of Chromatography A 1366, pages 110-119.
Crossref
Crossref
Sidney Roberto Nadal & Luis Roberto Manzione Nadal. (2021) Prophylactic vaccines for patients with human papillomavirus diseases (HPV). Journal of Coloproctology 34:01, pages 001-003.
Crossref
Crossref
Angel Chao, Cheng-Tao Lin & Chyong-Huey Lai. (2014) Updates in Systemic Treatment for Metastatic Cervical Cancer. Current Treatment Options in Oncology 15:1, pages 1-13.
Crossref
Crossref
Franco M Buonaguro & Luigi BuonaguroJoshua W WangRichard BS RodenMaria Lina TorneselloFranco M Buonaguro. 2014. Virus-like Particles in Vaccine Development. Virus-like Particles in Vaccine Development
22
34
.
Su-Eun Han, Mi-Gyeong Kim, Soondong Lee, Hee-Jeong Cho, Youngro Byun, Sujeong Kim, Young Bong Kim, Yongseok Choi & Yu-Kyoung Oh. (2013) Initial preclinical safety of non-replicating human endogenous retrovirus envelope protein-coated baculovirus vector-based vaccines against human papillomavirus. Journal of Applied Toxicology 33:12, pages 1474-1483.
Crossref
Crossref
Ravi Ranjan Verma, Rajan Sriraman, Samir Kumar Rana, N.M. Ponnanna, Burki Rajendar, Priyanka Ghantasala, Lingala Rajendra, Ramesh V. Matur & Villupanoor Alwar Srinivasan. (2013) E6 protein of human papillomavirus 16 (HPV16) expressed in Escherichia coli sans a stretch of hydrophobic amino acids, enables purification of GST-?E6 in the soluble form and retains the binding ability to p53. Protein Expression and Purification 92:1, pages 41-47.
Crossref
Crossref
Leda Gattoc, Navya Nair & Kevin Ault. (2013) Human Papillomavirus Vaccination. Obstetrics and Gynecology Clinics of North America 40:2, pages 177-197.
Crossref
Crossref
Marisol Fassolari, Lucia B. Chemes, Mariana Gallo, Clara Smal, Ignacio E. Sánchez & Gonzalo de Prat-Gay. (2013) Minute Time Scale Prolyl Isomerization Governs Antibody Recognition of an Intrinsically Disordered Immunodominant Epitope. Journal of Biological Chemistry 288:18, pages 13110-13123.
Crossref
Crossref
Yufeng Yao, Weiwei Huang, Xu Yang, Wenjia Sun, Xin Liu, Wei Cun & Yanbing Ma. (2013) HPV-16 E6 and E7 protein T cell epitopes prediction analysis based on distributions of HLA-A loci across populations: An in silico approach. Vaccine 31:18, pages 2289-2294.
Crossref
Crossref
Koen OosterhuisEsil AleydKim VrijlandTon N. SchumacherJohn B. Haanen. (2012) Rational Design of DNA Vaccines for the Induction of Human Papillomavirus Type 16 E6- and E7-Specific Cytotoxic T-Cell Responses. Human Gene Therapy 23:12, pages 1301-1312.
Crossref
Crossref
Antonia Radaelli, Carlo De Giuli Morghen, Carlo Zanotto, Sole Pacchioni, Massimiliano Bissa, Rosella Franconi, Silvia Massa, Francesca Paolini, Antonio Muller & Aldo Venuti. (2012) A prime/boost strategy by DNA/fowlpox recombinants expressing a mutant E7 protein for the immunotherapy of HPV-associated cancers. Virus Research 170:1-2, pages 44-52.
Crossref
Crossref
Charles C. L. Tong, Johnny Kao & Andrew G. Sikora. (2012) Recognizing and reversing the immunosuppressive tumor microenvironment of head and neck cancer. Immunologic Research 54:1-3, pages 266-274.
Crossref
Crossref
Hee-Jung Lee, Yoon-Ki Hur, Youn-Dong Cho, Mi-Gyeong Kim, Hoon-Taek Lee, Yu-Kyoung Oh & Young Bong Kim. (2012) Immunogenicity of Bivalent Human Papillomavirus DNA Vaccine Using Human Endogenous Retrovirus Envelope-Coated Baculoviral Vectors in Mice and Pigs. PLoS ONE 7:11, pages e50296.
Crossref
Crossref
Kelly Barrios & Esteban Celis. (2012) TriVax-HPV: an improved peptide-based therapeutic vaccination strategy against human papillomavirus-induced cancers. Cancer Immunology, Immunotherapy 61:8, pages 1307-1317.
Crossref
Crossref
María L. Cerutti, Leonardo G. Alonso, Silvio Tatti & Gonzalo de Prat‐Gay. (2011) Long‐lasting immunoprotective and therapeutic effects of a hyperstable E7 oligomer based vaccine in a murine human papillomavirus tumor model. International Journal of Cancer 130:8, pages 1813-1820.
Crossref
Crossref
Qingrui You, Chunlai Jiang, Wei Kong & Yongge Wu. (2012)
Attempted immunotherapy for
Mycobacterium tuberculosis
with viral and protein vaccines based on Ag85B-ESAT6 in a mouse model
. Acta Microbiologica et Immunologica Hungarica 59:1, pages 63-75.
Crossref
Crossref
Nadine C. Olthof, Jos M.J.A.A. Straetmans, Robert Snoeck, Frans C.S. Ramaekers, Bernd Kremer & Ernst‐Jan M. Speel. (2011) Next‐generation treatment strategies for human papillomavirus‐related head and neck squamous cell carcinoma: where do we go?. Reviews in Medical Virology 22:2, pages 88-105.
Crossref
Crossref
Chien-Fu Hung, Barbara Ma, Yijie Xu & T.-C. Wu. 2012. Gene Vaccines. Gene Vaccines
37
65
.
Franco Borruto & Ciro Comparetto. 2012. HPV and Cervical Cancer. HPV and Cervical Cancer
273
326
.
X.H. Mao, X.Z. Chen, W.W. Zhang, J.Y. Wang, L.F. Liu, Q. Zhou, K.J. Zhu & H. Cheng. (2011) TLR agonists activate HPV11 E7-pulsed DCs to promote a specific T cell response in a murine model. Veterinární medicína 56:12, pages 602-611.
Crossref
Crossref
Franco M BuonaguroEdward P RybickiColomba GiorgiRosella Franconi. 2011. Plant-derived Vaccines: Technologies & Applications. Plant-derived Vaccines: Technologies & Applications
68
80
.
Darin A. Wick & John R. Webb. (2011) A novel, broad spectrum therapeutic HPV vaccine targeting the E7 proteins of HPV16, 18, 31, 45 and 52 that elicits potent E7-specific CD8T cell immunity and regression of large, established, E7-expressing TC-1 tumors. Vaccine 29:44, pages 7857-7866.
Crossref
Crossref
Qi ZengShiwen PengArchana MonieMing YangXiaowu PangChien-Fu HungT.-C. Wu. (2011) Control of Cervicovaginal HPV-16 E7-Expressing Tumors by the Combination of Therapeutic HPV Vaccination and Vascular Disrupting Agents. Human Gene Therapy 22:7, pages 809-819.
Crossref
Crossref
Y Liu, S Tuve, J Persson, I Beyer, R Yumul, Z Y Li, K Tragoolpua, K-E Hellström, S Roffler & A Lieber. (2011) Adenovirus-mediated intratumoral expression of immunostimulatory proteins in combination with systemic Treg inactivation induces tumor-destructive immune responses in mouse models. Cancer Gene Therapy 18:6, pages 407-418.
Crossref
Crossref
A Wu, Q Zeng, T H Kang, S Peng, E Roosinovich, S I Pai & C-F Hung. (2010) Innovative DNA vaccine for human papillomavirus (HPV)-associated head and neck cancer. Gene Therapy 18:3, pages 304-312.
Crossref
Crossref
Tae Heung Kang, Archana Monie, Lee S.-F. Wu, Xiaowu Pang, Chien-Fu Hung & T.-C. Wu. (2011) Enhancement of protein vaccine potency by in vivo electroporation mediated intramuscular injection. Vaccine 29:5, pages 1082-1089.
Crossref
Crossref
Wen-Chung Chen, Barbara Ma, Chih-Ping Mao & T-C Wu. 2011. Pre-Invasive Disease: Pathogenesis and Clinical Management. Pre-Invasive Disease: Pathogenesis and Clinical Management
437
466
.
Antonia Radaelli, Eleana Pozzi, Sole Pacchioni, Carlo Zanotto & Carlo De Giuli Morghen. (2010) Fowlpox virus recombinants expressing HPV-16 E6 and E7 oncogenes for the therapy of cervical carcinoma elicit humoral and cell-mediated responses in rabbits. Journal of Translational Medicine 8:1.
Crossref
Crossref
J Dillner, M Arbyn, E Unger & L Dillner. (2011) Monitoring of human papillomavirus vaccination. Clinical and Experimental Immunology 163:1, pages 17-25.
Crossref
Crossref
Jae-Min Song, Yeu-Chun Kim, Aleksandr S. Lipatov, Marc Pearton, C. Todd Davis, Dae-Goon Yoo, Kyoung-Mi Park, Li-Mei Chen, Fu-Shi Quan, James C. Birchall, Ruben O. Donis, Mark R. Prausnitz, Richard W. Compans & Sang-Moo Kang. (2010) Microneedle Delivery of H5N1 Influenza Virus-Like Particles to the Skin Induces Long-Lasting B- and T-Cell Responses in Mice. Clinical and Vaccine Immunology 17:9, pages 1381-1389.
Crossref
Crossref
Martha H. Viera, Sadegh Amini, Ran Huo, Sailesh Konda, Samantha Block & Brian Berman. (2010) Herpes simplex virus and human papillomavirus genital infections: new and investigational therapeutic options. International Journal of Dermatology 49:7, pages 733-749.
Crossref
Crossref
Corinna Hoffmann, Christopher Bachran, Jonas Stanke, Sefer Elezkurtaj, Andreas M. Kaufmann, Hendrick Fuchs, Christoph Loddenkemper, Achim Schneider & Günter Cichon. (2010) Creation and characterization of a xenograft model for human cervical cancer. Gynecologic Oncology 118:1, pages 76-80.
Crossref
Crossref
Yu-Qian Zhang, Ya-Chea Tsai, Archana Monie, Chien-Fu Hung & T.-C. Wu. (2010) Carrageenan as an adjuvant to enhance peptide-based vaccine potency. Vaccine 28:32, pages 5212-5219.
Crossref
Crossref
Ken Lin, Elena Roosinovich, Barbara Ma, Chien-Fu Hung & T.-C. Wu. (2010) Therapeutic HPV DNA vaccines. Immunologic Research 47:1-3, pages 86-112.
Crossref
Crossref
Sidney Roberto Nadal & Carmen Ruth Manzione. (2010) Vacina contra o papilomavirus humano. O que é preciso saber?. Revista Brasileira de Coloproctologia 30:2, pages 237-240.
Crossref
Crossref
Jun-Han Su, Anjui Wu, Elizabeth Scotney, Barbara Ma, Archana Monie, Chien-Fu Hung & T.-C. Wu. (2010) Immunotherapy for Cervical Cancer. BioDrugs 24:2, pages 109-129.
Crossref
Crossref
T H Kang, J-Y Chung, A Monie, S I Pai, C-F Hung & T-C Wu. (2009) Enhancing DNA vaccine potency by co-administration of xenogenic MHC class-I DNA. Gene Therapy 17:4, pages 531-540.
Crossref
Crossref
Raphael P. Viscidi & Keerti V. Shah. 2010. Infectious Diseases. Infectious Diseases
1565
1569
.
Xian-Zhen Chen, Xiao-Hong Mao, Ke-Jian Zhu, Na Jin, Jun Ye, Jian-Ping Cen, Qiang Zhou & Hao Cheng. (2009) Toll like receptor agonists augment HPV 11 E7-specific T cell responses by modulating monocyte-derived dendritic cells. Archives of Dermatological Research 302:1, pages 57-65.
Crossref
Crossref
Yin Ling Woo, Muriel van den Hende, Jane C. Sterling, Nicholas Coleman, Robin A.F. Crawford, Kitty M.C. Kwappenberg, Margaret A. Stanley & Sjoerd H. van der Burg. (2009) A prospective study on the natural course of low‐grade squamous intraepithelial lesions and the presence of HPV16 E2‐, E6‐ and E7‐specific T‐cell responses. International Journal of Cancer 126:1, pages 133-141.
Crossref
Crossref
Matthew N. Davies & Darren R. Flower. 2009. Pharmaceutical Data Mining. Pharmaceutical Data Mining
317
338
.
Karina Dantur, Leonardo Alonso, Eduardo Castaño, Laura Morelli, Juan Manuel Centeno‐Crowley, Susana Vighi & Gonzalo de Prat‐Gay. (2009) Cytosolic accumulation of HPV16 E7 oligomers supports different transformation routes for the prototypic viral oncoprotein: The amyloid–cancer connection. International Journal of Cancer 125:8, pages 1902-1911.
Crossref
Crossref
P. Di Bonito, F. Grasso, G. Mangino, S. Massa, E. Illiano, R. Franconi, E. Fanales-Belasio, M. Falchi, E. Affabris & C. Giorgi. (2009) Immunomodulatory Activity of a Plant Extract Containing Human Papillomavirus 16-E7 Protein in Human Monocyte-Derived Dendritic Cells. International Journal of Immunopathology and Pharmacology 22:4, pages 967-978.
Crossref
Crossref
Kent A. Smith, Brenna L. Meisenburg, Victor L. Tam, Robb R. Pagarigan, Raymond Wong, Diljeet K. Joea, Liz Lantzy, Mayra A. Carrillo, Todd M. Gross, Uriel M. Malyankar, Chih-Sheng Chiang, Diane M. Da Silva, Thomas M. Kündig, W. Martin Kast, Zhiyong Qiu & Adrian Bot. (2009) Lymph Node–Targeted Immunotherapy Mediates Potent Immunity Resulting in Regression of Isolated or Metastatic Human Papillomavirus–Transformed Tumors. Clinical Cancer Research 15:19, pages 6167-6176.
Crossref
Crossref
Minzhen Xu, Xueqing Lu, Margaret Sposato, John W. Zinckgraf, Shuzhen Wu & Eric von Hofe. (2009) Ii-Key/HPV16 E7 hybrid peptide immunotherapy for HPV16+ cancers. Vaccine 27:34, pages 4641-4647.
Crossref
Crossref
Lucy A. Perrone, Attiya Ahmad, Vic Veguilla, Xiuhua Lu, Gale Smith, Jacqueline M. Katz, Peter Pushko & Terrence M. Tumpey. (2009) Intranasal Vaccination with 1918 Influenza Virus-Like Particles Protects Mice and Ferrets from Lethal 1918 and H5N1 Influenza Virus Challenge. Journal of Virology 83:11, pages 5726-5734.
Crossref
Crossref
Paulo Cesar Maciag, Sini?a Radulovic & John Rothman. (2009) The first clinical use of a live-attenuated Listeria monocytogenes vaccine: A Phase I safety study of Lm-LLO-E7 in patients with advanced carcinoma of the cervix. Vaccine 27:30, pages 3975-3983.
Crossref
Crossref
Eleana Pozzi, Valeria Basavecchia, Carlo Zanotto, Sole Pacchioni, Carlo De Giuli Morghen & Antonia Radaelli. (2009) Construction and characterization of recombinant fowlpox viruses expressing human papilloma virus E6 and E7 oncoproteins. Journal of Virological Methods 158:1-2, pages 184-189.
Crossref
Crossref
Therese Buskas, Pamela Thompson & Geert‐Jan Boons. 2009. Carbohydrate‐Based Vaccines and Immunotherapies. Carbohydrate‐Based Vaccines and Immunotherapies
263
311
.
Krishnansu S. Tewari & Bradley J. Monk. (2009) Recent Achievements and Future Developments in Advanced and Recurrent Cervical Cancer: Trials of the Gynecologic Oncology Group. Seminars in Oncology 36:2, pages 170-180.
Crossref
Crossref
Suzanne A. Miles & Anthony D. Sandler. (2009) CpG oligonucleotides for immunotherapeutic treatment of neuroblastoma. Advanced Drug Delivery Reviews 61:3, pages 275-282.
Crossref
Crossref
. (2009) Current World Literature. Current Opinion in Obstetrics & Gynecology 21:1, pages 101-109.
Crossref
Crossref
Swati Patel & Shubhada Chiplunkar. (2009) Host immune responses to cervical cancer. Current Opinion in Obstetrics & Gynecology 21:1, pages 54-59.
Crossref
Crossref
Alberto Rosenblatt & Homero Gustavo Campos GuidiAlberto Rosenblatt & Homero Gustavo de Campos Guidi. 2009. Human Papillomavirus. Human Papillomavirus
195
214
.
Matthew N. Davies & Darren R. Flower. 2010. Bioinformatics for Immunomics. Bioinformatics for Immunomics
1
20
.